Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cambrex Corporation
Shawn P. Cavanagh named senior VP and GM of diversified life sciences company
November 4th, 2005
Cambrex Corporation (CBM) announced that Shawn P. Cavanagh has been appointed senior vice president and general manager, Cambrex Bioproducts, and that N. David Eansor, formerly head of Bioproducts, has resigned to pursue other interests. Cavanagh joined Cambrex in October 1999 with the acquisition of FMC BioProducts. In 2000, he was promoted to the position of global director, Endotoxin Detection, and in 2004, to the position of vice president, Bioproducts. Prior to joining Cambrex, Cavanagh held various management and engineering positions with FMC BioProducts. Cambrex is a global, diversified life sciences company providing...
Source: Biotech Law Weekly (2005-11-04)
|
